Navigation Links
The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to Their Patients

Poway, California (PRWEB) September 12, 2013

The Arrow Group of Animal Hospitals, out of Glendale, Arizona and their 17 Phoenix Metro area veterinary hospitals have partnered with California based Vet-Stem, Inc., the leading Regenerative Veterinary Medicine company, to bring stem cell therapy to their patients. Dogs that are suffering pain or inflammation from osteoarthritis or polyarthritis, joint or ligament issues, or muscle injuries, can now receive stem cell therapy.

The Arrow Group of Animal Hospitals hosted Vet-Stem’s Corey Orava, DVM for a week of training sessions to help all of their staff learn the ins and outs of stem cell therapy. Veterinarians and technicians benefited from hands-on labs and a continuing education course that will help them bring the best care to their patients and pet owners. Under the mentorship of Dr. Orava Dobson Ranch Animal Hospital, Fletcher Heights Animal Hospital, Surprise Animal Hospital and Animal Hospital at Anthem were able to perform their debut stem cell therapy cases during their initial week of offering the new service.

The Arrow Group of Animal Hospitals is a co-operative group of 17 individual small animal hospitals around the valley that are proud to offer the highest quality veterinary care possible. The doctors and staff at each hospital strive to build a long term relationship with their client families and their pets, always making recommendations in the pet’s best health interest. The Arrow Group of Animal Hospitals offer complete veterinary care from wellness, to vaccines, spays and neuters, dental, surgical and now regenerative medicine. Their animal hospital locations can be easily found at    

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit or call 858-748-2004.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
2. Darrow Wealth Management Launches New Website
3. Laser mastery narrows down sources of superconductivity
4. Barrow researchers unravel illusion
5. Researchers realize high-power, narrowband terahertz source at room temperature
6. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
7. RGF Environmental Group Acquires AFL Industries
8. Medflow EHR Achieves ONC-ACB Certification by Drummond Group
9. Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
10. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
11. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
Post Your Comments:
(Date:11/24/2015)... ... 2015 , ... Copper is an essential micronutrient that all ... copper is also toxic to cells. With a $1.3 million award from the ... a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
(Date:11/24/2015)... --> --> ... by Transparency Market Research, the global non-invasive prenatal testing ... 17.5% during the period between 2014 and 2022. The ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... to reach a valuation of US$2.38 bn by 2022. ...
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh industrial processes, the ... in-line sensors can represent a weak spot where leaking process media is a ... sensor housings , which are designed to tolerate extreme process conditions. They combine ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):